CI
Cingulate Inc. Warrants (CINGW)
NASDAQ·Healthcare·Biotechnology
$0.01
-27.71%
Mkt Cap $296.48K
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$234.60
Range $159.12 – $275.40
Implied Upside
+1954900.0%
Consensus $234.60 vs current $0.01